ma
Archive for 2015 Archive for 2014 Archive for 2013 Archive for 2012 Archive for 2011 Archive for 2010 Archive for 2009 Archive for 2008 Archive for 2007 Archive for 2006
Archive for 2005 Archive for 2004 Archive for 2003 Archive for 2002 Archive for 2001 Archive for 2000 Archive for 1999 Archive for 1998 Archive for 1997


2014 Archive
(listed in reverse chronological order)

December 22, 2014

McGrath  

Thadhani  
Brigham Board Review Course   
Boston, MA; August, 2013

Hematuria - Board Review
Martina M. McGrath, MD

Pregnancy and Renal Disease
Ravi Thadhani, MD



Esezobor  

Onuigbo  

Gupta  

Daugirdas  
Advances in CKD 2014
(PART 8)
  
Renal Research Institute
Las Vegas, NV; January, 2014

PART EIGHT

Peritoneal Dialysis for Children with AKI in Nigeria: Saving Young Lives with Improvisations
Christopher Esezobor, MD

CKD Predictions and Concepts of progresses and non-progresses
Macaulay Onuigbo, MD

Circulating Fibroblast Growth Factor-2 (FGF-2) induces proteinuria and glomerular injury in young mice
Charu Gupta, MD

Keynote Address: A Different Approach to the Dialysis Prescription
John Daugirdas, MD

 
 

October 31, 2014

Misra  

Ding  

Gura  

Chen  

Canaud  

Huang  

Jo  

Yu  

Marshall  

 
ISHD Hemodialysis University™ 2013 Shanghai Update
(PARTS 5 through 9)
  
International Society for Hemodialysis
Shanghai, China; April, 2013

Part 9
Blood Pressure on Dialysis: Salt volume, RRF and beyond
Madhukar Misra, MD

Anemia in Hemodialysis Patients
Andrew Davenport, MD

Part 8
The Artificial wearable Kidney - Status
Victor Gura, MD

Infection control in the Hemodialysis Unit
Victor Gura, MD

Anemia in Hemodialysis Patients
Hung-Chun Chen, MD

Part 7
When to initiate Dialysis: Early or Late and Why?
Bernard Canaud, MD

Timing and dose of RRT in Acute Kidney Injury
Mark R Marshall, MD

Part 6
Hepatitis in hemodialysis patients
Chiu-Chin Huang, MD

Immune dysfunction in HD patients
Sang Kyung Jo, MD

Part 5
Choice in Dialysis Modality
Xueqing Yu MD

RRT in Acute Kidney Injury: A comparative overview of available therapies
Mark R Marshall, MD


Dember  
Brigham Board Review Course   
Boston, MA; August, 2013

Paraprotein Related Kidney Diseases
Laura M. Dember, MD



Appel  

Betjes  

Ghaffari  

Kuhlmann  
Advances in CKD 2014
(PART 7)
  
Renal Research Institute
Las Vegas, NV; January, 2014

PART SEVEN

Progression of CKD: The role of APOL1 and other recent advances Oral Anticoagulation in Advanced Kidney Disease
Lawrence J. Appel, MD

Smouldering immunologic derangements in ESRD. What are the implications?
Michiel G.H. Betjes, MD

Urgent-Start PD: Patient benefits or financial incentives?
Arshia Ghaffari, MD

Is the Mediterranean diet better than the current approach of protein restriction in pre dialysis CKD?
Martin Kuhlmann, MD

 
 

September 4, 2014

Ding  

Kerr  

Itami  

Canaud  

Urbanes  

   
ISHD Hemodialysis University™ 2013 Shanghai Update
(PARTS 3 and 4)
  
International Society for Hemodialysis
Shanghai, China; April, 2013

PART FOUR
Uremic toxins: An Overview and Update
Xiao-qiang Ding, MD

Maximizing the benefits of HD: More long or more frequent
Peter G Kerr, MD

Application and clinical effect of CDDS in Japan
Noritomo Itami, MD

PART THREE
Basics of Water Quality in the Hemodialysis unit
Peter G Kerr , MD

Hemodialysis Adequacy in 2013
Bernard Canaud, MD

Taming the beast: Chronic Hemodialysis Cather
Aris Q Urbanes, MD


Suri  

Hammond  
Brigham Board Review Course   
Boston, MA; August, 2013

Home Dialysis Cases
Rita Suri, MD

Infections in Immunocompromised Hosts
Sarah P. Hammond, MD



Zoccali  

Pecoits-Filho  

McIntyre  

Aliotta  
Advances in CKD 2014
(PART 6)
  
Renal Research Institute
Las Vegas, NV; January, 2014

PART SIX

Subclinical thyroid dysfunction and clinical outcomes in end stage kidney disease
Carmine Zoccali, MD

Debate: Endotoxemia in CKD is primarily a fluid overload phenomenon
  Yes: Roberto Pecoits-Filho, MD
  No: Chris W. McIntyre, MD

Regenerative medicine - What are the prospects in nephrology?
Jason M. Aliotta, MD

 
 

June 30, 2014

Misra  

Ding  

Cai  

Davenport  

Li  

Urbanes  
ISHD Hemodialysis University™ 2013 Shanghai Update
(PARTS 1 and 2)
  
International Society for Hemodialysis
Shanghai, China; April, 2013

Parts ONE and TWO

ISHD Hemodialysis University, Shanghai Update: Opening Ceremony
Madhukar Misra, MD (ISHD President and Course Co-Director) and Ding Xiaoqiang, MD, PhD, (Course Co-Director)

Prof. Liao Lutanís Lifetime Achievement Award
Madhukar Misra, MD

Essentials of a hemodialysis machine: What does a nephrologist need to know?
Madhukar Misra, MD

Dialysis in China: Current status and Challenge
Guang-yan Cai MD

Dialysate Sodium in HD: What is important to know?
Andrew Davenport MD

Dialyzer Membrane Permeability: Effect on Cardiovascular Outcome
Philip Li, MD

Getting it right: Planning, Monitoring, and Maintaining the Dialysis AVF
Aris Q Urbanes, MD


Christopher  
Brigham Board Review Course   
Boston, MA; August, 2013

CVVH for the Boards
Kenneth B. Christopher, MD



Levin  

Collins  

Unruh  

McIntyre  

Cochat  

Grantham  
Advances in CKD 2014
(PARTS 4 and 5)
  
Renal Research Institute
Las Vegas, NV; January, 2014

Parts FOUR and FIVE

CKD progression predictors in 2014
Adeera Levin, MD

Epidemiology of dialysis withdrawal
Allan J. Collins, MD

Are the current ethical standards for dialysis withdrawal adequate?
Mark Unruh, MD

Keynote Address: Brain damage in pre-dialysis CKD, HD, and PD
Chris W. McIntyre, MD

The issue of the solitary kidney
Pierre Cochat, MD

Recent advances in polycystic kidney disease research with emphasis on therapy
Jared Grantham, MD

 
 

May 31, 2014

Yu  
Brigham Board Review Course   
Boston, MA; August, 2013

Electrolytes and Acid Base Practice for the Boards
Alan S.L. Yu, MD



Maduell  

Ketchersid  

Titze  

Zoccali  

Power  
 
Advances in CKD 2014
(PARTS 2 and 3)
  
Renal Research Institute
Las Vegas, NV; January, 2014

Part TWO
Three RCTs in HDF: A critical analysis and implications for future use
Francisco Maduell, MD

ďBig DataĒ in nephrology: friend or foe?
Terry Ketchersid, MD

Keynote Address: Non-osmotic sodium storage as a pathogenetic factor in hypertension in CKD & ESRD
Jens Titze, MD

PART THREE
Lung congestion as a risk factor in end stage renal disease
Carmine Zoccali, FASN

Stroke in Dialysis and CKD
Albert Power, MD

 
 
 

April 30, 2014

Appel  
Brigham Board Review Course   
Boston, MA; August, 2013

IgA Nephropathy
Gerald A. Appel, MD



Kotanko  

Weintraub  

Ok  

Nissenson  
Advances in CKD 2014
(PART 1)
  
Renal Research Institute
Las Vegas, NV; January, 2014

Welcome
Peter Kotanko, MD

The spectrum of CKD - a patientís journey
Judy Weintraub, MS Ed

The balance between dialysis duration and sodium restriction in volume control
Ercan Ok, MD

Accountable Care Organizations and ESRD
Allen R. Nissenson, MD

 

Kuritzky  

Bakris  

Basile  

Ferdinand  

Deedwania  

Iadecola  
American Society of Hypertension Annual Scientific Meeting
(Parts 16-21 )
  
San Francisco, CA; May 2013

MANAGEMENT ISSUES IN HYPERTENSION: TRICKS OF THE TRADE
Hypertension Urgencies and Emergencies
Louis Kuritzky, MD

HYPERTENSION FOR THE PRIMARY CARE CLINICIAN 2013
Case-1: Discussion
George L. Bakris, MD, Jan N. Basile, MD, and Keith C. Ferdinand, MD

Case-2: Discussion
George L. Bakris, MD, Jan N. Basile, MD, and Keith C. Ferdinand, MD

NEW CONSIDERATIONS IN DYSLIPIDEMIA AND CARDIOMETABOLIC DISORDERS
Management of Dyslipidemias in Patients with Hypertension, Diabetes and Metabolic Syndrome
Prakash C. Deedwania, MD

VASCULAR WALL SIGNALING: HOW ARE CELLS COUPLED?
Endothelin Role in Neurovascular Regulation and Dysregulation
Costantino Iadecola, MD

BLOOD PRESSURE TARGETS FOR PRIMARY CARE
What Should Be the Initial Pharmacologic Therapy
Barry L. Carter, PharmD

LATE BREAKING CLINICAL TRIALS
Cardiovascular Effects Based on Magnitude of WL in Obese/Overweight Subjects with Hypertension Receiving Phentermine and Topiramate Extended-Release
George Bakris, MD

 
 

March 31, 2014

Ram  

Calhoun  

White  

Yarows  

Viera  

Mizuno  

Flynn  

Oparil  

Basile  

Bakris  
American Society of Hypertension Annual Scientific Meeting
(Parts 11-15 )
  
San Francisco, CA; May 2013

Part 15. PLENARY SESSION
Marvin Moser Clinical Hypertension Award Lecture - Treatment of Hypertension: From Drugs to Devices
C. Venkata S. Ram, MD

Part 14. NOCTURNAL BP
The Treatment of Hypertension Should be Targeted Towards the Nocturnal Blood Pressure - Antagonist
David A. Calhoun, MD

Part 13. HOME BP AND AMBULATORY BP MONITORING
Home and Ambulatory Blood Pressure Monitoring: Review of the ASH Position Paper
William B. White, MD

Implementing ABPM into Your Practice
Steven A. Yarows, MD

Interpreting the Data in Adult and Pediatric Populations: A Case-Based Approach
Anthony J. Viera, MD

Part 12. SPECIAL POPULATIONS
The Asian Hypertensive
Eric T. Mizuno, MD

Adolescents with Hypertension
Joseph T. Flynn, MD

Part 11. UPDATE ON RESISTANT HYPERTENSION
Resistant Hypertension: Incidence, Prevalence, and Pathophysiology
Suzanne Oparil, MD

Patient Case: The Resistant Hypertensive Patient Who Remains Uncontrolled
Jan N. Basile, MD

Symplicity HTN-3 and Resistant Hypertension
George L. Bakris, MD

 
 

February 26, 2014

Flack  

Taylor  

Weir  

Cushman  

Taler  

Agarwal  

Woo  

Steinberger  

Carter  

Marrs  

Arnett  

Meyer  

Wesson  

Textor  
American Society of Hypertension Annual Scientific Meeting
(Parts 6-10 )
  
San Francisco, CA; May 2013

PART 6
WITHIN-CLASS DIFFERENCES IN ANTIHYPERTENSIVE THERAPIES

The Diuretics
John M. Flack, MD

The Beta Blockers
Addison A. Taylor, MD

The ACE Inhibitors and ARBs
Matthew R. Weir, MD

PART 7
WHAT SHOULD TARGET BLOOD PRESSURE BE?

Con: What Should the Target Blood Pressure Be in Diabetic Patients? 130/80 is the Goal
William C. Cushman, MD

Pro: What Should the Target Blood Pressure Be in CKD Patients? 130/80 is the Goal
Sandra J. Taler, MD

Con: What Should the Target Blood Pressure Be in CKD Patients? 130/80 is the Goal
Rajiv Agarwal, MD

PART 8
CHILDHOOD COHORTS: WHAT CAN THEY TEACH US ABOUT ADULT HYPERTENSION AND CARDIOMETABOLIC DISEASE?
Princeton School Study and NHLBI Growth and Health Study: Obesity and Secular Trends in Blood Pressure
Jessica G. Woo, PhD

Minneapolis Blood Pressure Studies: Insulin Resistance and Blood Pressure
Julia Steinberger, MD

PART 9
ELEMENTS OF RESISTANT HYPERTENSION: A FOCUS ON PHARMACOKINETICS AND PHARMACODYNAMICS

Assessment of Adherence
Barry L. Carter, PharmD

Methods for Improving Adherence
Joel C. Marrs, PharmD

Use of Generic Medications in Resistant Hypertension Rhonda Cooper-DeHoff, PharmD Pharmacogenetic Factors in Blood Pressure Control
Donna K. Arnett, PhD

PART 10
BEYOND BLOOD PRESSURE: PROTECTING THE KIDNEY

Uremic Toxicity
Timothy W. Meyer, MD

Alkali Therapy
Donald Wesson, MD

Hypoxia as the Common Pathway to Nephron Loss
Steven C. Textor, MD

 
 

January 31, 2014

Niles  
Brigham Board Review Course   
Boston, MA; August, 2012

Rapidly Progressive Glomerulonephritis, Parts 1 and 2
John Niles, MD



Bergman  

Oparil  

Sandoval  

Iadecola  

Calhoun  

Coooper  

Pohl  

Weir  

Bakris  

 
American Society of Hypertension Annual Scientific Meeting
(Parts 2-5 )
  
San Francisco, CA; May 2013

OBESITY AND CARDIOMETABOLIC DISEASES

Adipocytes as Regulators of Metabolic Balance
Richard N. Bergman, PhD

Pharmacologic Treatments for Obesity
Suzanne Oparil, MD (audio only)

Bariatric Surgery: Metabolic and Blood Pressure Effects
Darleen Sandoval, PhD

HYPERTENSION: A MULTISYSTEM DISEASE

Brain and Hypertension
Costantino Iadecola, MD

NEW CONCEPTS IN THE MANAGEMENT OF REFRACTORY HYPERTENSION AND RENAL ARTERY STENOSIS Diagnostic Approach and Treatment of Resistant Hypertension
David A. Calhoun, MD

Atherosclerotic Renal Artery Stenosis: Where Do We Go if CORAL is a Negative Trial?
Christopher J. Cooper, MD

Renal Fibromuscular Dysplasia
Marc A. Pohl, MD (audio only)

HYPERKALEMIA AND HYPERTENSION: NEW CONSIDERATIONS

Cardio-Renal Risk Reduction and Potassium Management in the Hypertensive Patient
Matthew R. Weir, MD

Management Strategies for Elevated Potassium Levels and Cardiovascular Outcomes
George L. Bakris, MD

 

Urbanes  

Lok  

May  

Hentschel  

Illig  

Samaha  

Fox  

Haskal  

Rajan  

Lee  

Lawson  

Peden  

Pflederer  

Blaser  

Wasse  

Veseley  

 

Falk  
ASDIN Annual Scientific Meeting (Parts 11-19)   
Washington, DC; February, 2013

PART 11 New Initiatives for ASDIN Affiliation and Collaboration

Aris Urbanes, MD

Vascular access procedures and infection: time for evidence-based policy
Charmaine Lok, MD

Developing Internventional Nephrology in Australia/New Zealand
Stephen May, MD

PART 14 ACCESS COMPLICATIONS: High Flow AVFs

Recognition and Diagnosis of high-flow fistula
Dirk Hentschel, MD

Surgical treatment options for the "Mega-AVF"
Karl A. Illig, MD

Endovascular treatment options for the "Mega-AVF"
Tony Samaha, MD

PART 15 ACCESS COMPLICATIONS: Point/Counterpoint

First line Treatment of Peripheral Vein Stenosis Should be With a Covered Stent
Ziv J. Haskal MD

Donít Stent: Surgical Management is Best
David Fox, MD

Symptomatic Central Venous Obstruction is Best Treated with PTA and Stenting
Dheeraj K. Rajan MD

Surgical Treatment is The Optimal for Symptomatic Central Venous Obstruction
Karl A. Illig, MD

PART 17 ADVANCES IN AV ACCESS

Arterial Elasticity and AVF maturation
William D. Paulson, MD

Pre-existing Vascular Calcification and AVF Maturation
Timmy Lee, MD

Tissue-engineered vascular grafts
Jeffrey H. Lawson, MD

Optiflow Vascular Anastomosis Device
Eric K. Peden, MD

Extending Access Site Patency with Novel Devices
Jeffrey H. Lawson, MD

PART 18

REALITY CHECK: BUSINESS AND POLICY OF AV ACCESS

Drug Shortages
Aris Q. Urbanes, MD

True Lies: Ethical Behavior when patient has not received optimal care
Timothy A. Pflederer, MD

Intersection of Regulatory Bodies
Robert Blaser, MD

The Economics of Fistula First
Timothy A. Pflederer, MD

Interventional Nephrology and the Accountable Care Organization Model
Robert Blaser, MD

Closing Remarks and Adjournment
Haimanot Wasse, MD

PART 19

NON-DIALYSIS PROCEDURES and TECHNIQUES

Port Placement, removal and Management
Thomas Vesely, MD (handout only)

IVC Filter: Indications, Placement, Complications
Dheeraj Rajan, MD (handout only)

Varicose Vein Therapy: An introduction to Surgical and Endovascular Treatment Abigail Falk, MD (handout only)

 

Annual Dialysis
Conference 2013
now in MP3
AUDIOFILE LIST (Annual Dialysis Conference 2013)
Special Situations in PD
Jean Holley, MD, and Joshua Botdorf, DO

Clinical and Administrative Issues: Quality Outcomes in Nephrology
Katrina Russell, RN, Jay Wish, MD, Caprice Vanderkolk, MS, RN, and Debbie Cote, MSN, RN

The Hypertensive Overhydrated Patient: Making Sense of Different Strategies
Peter Kotanko, MD, Bernard Canaud, MD, Ercan Ok, MD, and Christopher Chan, MD

PD Nursing Clinical Topics V
Elizabeth Kelman, MEd, RN, Ann Marie Correia, ASN, RN, Barbara Valle, BSN, RN, and Lisa Sotter, BSN, RN

Nutrition and Metabolism
Steven Guest, MD, Jean Holley, MD, Gautam Phadke, MD, and Georges Saab, MD

Persistent Challenges in Dialysis Therapies: Has There Been Progress?
Joanne Bargman, MD, and William Clark, MD

PD and HD Dialysis Catheters: Implantation and Care
W. Kirt Nichols, MD, John Crabtree, MD, Michael Tal, MD, and Anil Agarwal, MD






HDCN home
/about our site / subscribe to key zone / register for free zone
update email address / subscription status / forget your password?